Drug class · Endocrine & metabolism
GLP-1 receptor agonists Drug Codes & NDCs
Drugs that activate the glucagon-like peptide-1 (GLP-1) receptor. The class includes injectable and oral products; tirzepatide is also listed here because it acts on both the GLP-1 and GIP receptors.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Mounjarotirzepatide | Tirzepatide 2.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1152 |
| Mounjarotirzepatide | Tirzepatide 5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1243 |
| Mounjarotirzepatide | Tirzepatide 15 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1457 |
| Mounjarotirzepatide | Tirzepatide 12.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1460 |
| Mounjarotirzepatide | Tirzepatide 10 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1471 |
| Mounjarotirzepatide | Tirzepatide 7.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1484 |
| Mounjarotirzepatide | Tirzepatide 5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1495 |
| Mounjarotirzepatide | Tirzepatide 2.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1506 |
| Mounjarotirzepatide | Tirzepatide 7.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2214 |
| Mounjarotirzepatide | Tirzepatide 10 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2340 |
| Mounjarotirzepatide | Tirzepatide 12.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2423 |
| Mounjarotirzepatide | Tirzepatide 15 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3002 |
| Mounjarotirzepatide | Tirzepatide 4.17 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-4052 |
| Mounjarotirzepatide | Tirzepatide 8.33 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-4103 |
| Mounjarotirzepatide | Tirzepatide 12.5 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-4210 |
| Mounjarotirzepatide | Tirzepatide 16.7 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-4304 |
| Mounjarotirzepatide | Tirzepatide 20.8 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-4523 |
| Mounjarotirzepatide | Tirzepatide 25 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-4612 |
| Mounjarotirzepatide | Tirzepatide 10 mg/.5mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-8021 |
| Mounjarotirzepatide | Tirzepatide 12.5 mg/.5mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-8022 |
| Mounjarotirzepatide | Tirzepatide 7.5 mg/.5mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-8023 |
| Mounjarotirzepatide | Tirzepatide 5 mg/.5mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-8024 |
| Mounjarotirzepatide | Tirzepatide 2.5 mg/.5mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-8025 |
| Mounjarotirzepatide | Tirzepatide 15 mg/.5mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-8026 |
| Mounjaro KwikPentirzepatide | Tirzepatide 25 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3411 |